Exenatide oral (Shanghai Biolaxy)

N/A

Report date: 2025/01/08 10:01:18

Base Information

Drug NameExenatide oral (Shanghai Biolaxy)

Drug Alias NameNodexen

ClassificationSmall molecules > Synthetic peptide

Mechanisms of ActionGlucagon-like peptide 1 receptor agonists

TargetsGlucagon-like peptide 1 receptor

Therapy Area/IndicationsDiabetes Mellitus

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNod Pharma

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesNod Pharma

Active IndicationsN/A

Inactive IndicationsDiabetes Mellitus

ATC CodeN/A